ibrexafungerp
Generic: IBREXAFUNGERP CITRATE·Brand: BREXAFEMME
ibrexafungerp: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SCYNEXIS INC (SCYX) | Phase 3 |
Clinical Trials (1)
Phase 1, Open-Label Pharmacokinetic Study in Healthy Lactating Women After Two Oral Doses of Ibrexafungerp Administered on a Single Day
Frequently asked questions
Who is developing ibrexafungerp?
ibrexafungerp is being developed by SCYNEXIS INC.
How many clinical trials involve ibrexafungerp?
BioSniper tracks 1 clinical trial involving ibrexafungerp.
Get deeper analysis on ibrexafungerp
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis